发明名称 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
摘要 <p>The present invention relates to compounds of the formula I, &lt;CHEM&gt; in which B, G, Z, X, Y, r, s and t have the meanings indicated in the claims, their physiologically tolerable salts and their prodrugs. The compounds of the formula I are valuable pharmacologically active compounds. They are vitronectin receptor antagonists and inhibitors of cell adhesion and are suitable for the therapy and prophylaxis of illnesses which are based on the interaction between vitronectin receptors and their ligands in cell-cell or cell-matrix interaction processes or which can be prevented, alleviated or cured by influencing such interactions. For example, they can be applied for inhibiting bone resorption by osteoclasts and thus for treating and preventing osteoporosis, or for inhibiting undesired angiogenesis or proliferation of cells of the vascular smooth musculature. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.</p>
申请公布号 EP1065207(A1) 申请公布日期 2001.01.03
申请号 EP19990112636 申请日期 1999.07.02
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH;GENENTECH, INC. 发明人 PEYMAN, ANUSCHIRWAN DR.;SCHEUNEMANN, KARL-HEINZ DR.;GOURVEST, JEAN-FRANCOIS DR.;RUXER, JEAN-MARIE DR.;GADEK, THOMAS R. DR.
分类号 C07D519/00;A61K31/52;A61P9/08;A61P9/10;A61P13/12;A61P17/06;A61P19/02;A61P19/10;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07D473/34;(IPC1-7):C07D473/34 主分类号 C07D519/00
代理机构 代理人
主权项
地址